| FAIR VALUE |
FAIR VALUE Our “Financial instruments” and “Financial instrument liabilities” on our Condensed Consolidated Statements of Financial Condition are recorded at fair value. See Notes 2 and 4 of our 2025 Form 10-K for further information about such instruments and our significant accounting policies related to fair value. The following tables present assets and liabilities measured at fair value on a recurring basis. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ in millions | | Level 1 | | Level 2 | | Level 3 | | Netting adjustments (1) | | Balance as of March 31, 2026 | Assets at fair value on a recurring basis: | | | | | | | | | | | | | | | | | | | | | | | Trading assets: | | | | | | | | | | | | Municipal and provincial obligations | | $ | 11 | | | $ | 306 | | | $ | — | | | $ | — | | | $ | 317 | | | Corporate obligations | | 15 | | | 580 | | | — | | | — | | | 595 | | | Government and agency obligations | | 40 | | | 87 | | | — | | | — | | | 127 | | | Agency mortgage-backed securities (“MBS”), collateralized mortgage obligations (“CMOs”) and asset-backed securities (“ABS”) | | — | | | 214 | | | — | | | — | | | 214 | | | Non-agency CMOs and ABS | | — | | | 142 | | | — | | | — | | | 142 | | | Total debt securities | | 66 | | | 1,329 | | | — | | | — | | | 1,395 | | | Equity securities | | 12 | | | 6 | | | — | | | — | | | 18 | | | Brokered certificates of deposit | | — | | | 19 | | | — | | | — | | | 19 | | | Other | | — | | | — | | | 2 | | | — | | | 2 | | | Total trading assets | | 78 | | | 1,354 | | | 2 | | | — | | | 1,434 | | Available-for-sale securities (2) | | 423 | | | 5,979 | | | — | | | — | | | 6,402 | | | Derivative assets: | | | | | | | | | | | Interest rate | | 12 | | | 263 | | | — | | | (214) | | | 61 | | | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange | | — | | | 10 | | | — | | | — | | | 10 | | | | | | | | | | | | | | Total derivative assets | | 12 | | | 273 | | | — | | | (214) | | | 71 | | | | | | | | | | | | | | All other investments: | | | | | | | | | | | Government and agency obligations (3) | | 86 | | | — | | | — | | | — | | | 86 | | | Other | | 193 | | | 2 | | | 7 | | | — | | | 202 | | | Total all other investments | | 279 | | | 2 | | | 7 | | | — | | | 288 | | Other assets – client-owned fractional shares | | 188 | | | — | | | — | | | — | | | 188 | | | Subtotal | | 980 | | | 7,608 | | | 9 | | | (214) | | | 8,383 | | Other investments – private equity – measured at net asset value (“NAV”) | | | | | | | | | | 111 | | | Total assets at fair value on a recurring basis | | $ | 980 | | | $ | 7,608 | | | $ | 9 | | | $ | (214) | | | $ | 8,494 | | | | | | | | | | | | | | Liabilities at fair value on a recurring basis: | | | | | | | | | | | | Trading liabilities: | | | | | | | | | | | | Municipal and provincial obligations | | $ | 4 | | | $ | — | | | $ | — | | | $ | — | | | $ | 4 | | | Corporate obligations | | — | | | 469 | | | — | | | — | | | 469 | | | Government and agency obligations | | 212 | | | — | | | — | | | — | | | 212 | | | | | | | | | | | | | | | | | | | | | | | | | Total debt securities | | 216 | | | 469 | | | — | | | — | | | 685 | | | Equity securities | | 39 | | | 1 | | | — | | | — | | | 40 | | Other liabilities | | — | | | — | | | 1 | | | — | | | 1 | | | Total trading liabilities | | 255 | | | 470 | | | 1 | | | — | | | 726 | | | | | | | | | | | | | Derivative liabilities – interest rate | | 9 | | | 272 | | | — | | | (83) | | | 198 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Other payables – repurchase liabilities related to client-owned fractional shares | | 188 | | | — | | | — | | | — | | | 188 | | | Total liabilities at fair value on a recurring basis | | $ | 452 | | | $ | 742 | | | $ | 1 | | | $ | (83) | | | $ | 1,112 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ in millions | | Level 1 | | Level 2 | | Level 3 | | Netting adjustments (1) | | Balance as of September 30, 2025 | Assets at fair value on a recurring basis: | | | | | | | | | | | | | | | | | | | | | | | Trading assets: | | | | | | | | | | | Municipal and provincial obligations | | $ | 6 | | | $ | 403 | | | $ | — | | | $ | — | | | $ | 409 | | Corporate obligations | | 11 | | | 659 | | | — | | | — | | | 670 | | Government and agency obligations | | 41 | | | 108 | | | — | | | — | | | 149 | | | Agency MBS, CMOs, and ABS | | — | | | 231 | | | — | | | — | | | 231 | | | Non-agency CMOs and ABS | | — | | | 36 | | | — | | | — | | | 36 | | Total debt securities | | 58 | | | 1,437 | | | — | | | — | | | 1,495 | | Equity securities | | 17 | | | 3 | | | — | | | — | | | 20 | | Brokered certificates of deposit | | — | | | 19 | | | — | | | — | | | 19 | | Other | | — | | | — | | | 4 | | | — | | | 4 | | | Total trading assets | | 75 | | | 1,459 | | | 4 | | | — | | | 1,538 | | Available-for-sale securities (2) | | 430 | | | 6,458 | | | — | | | — | | | 6,888 | | | Derivative assets: | | | | | | | | | | | | Interest rate | | 2 | | | 304 | | | — | | | (239) | | | 67 | | | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange | | — | | | 1 | | | — | | | — | | | 1 | | | | | | | | | | | | | | Total derivative assets | | 2 | | | 305 | | | — | | | (239) | | | 68 | | | | | | | | | | | | | | All other investments: | | | | | | | | | | | Government and agency obligations (3) | | 92 | | | — | | | — | | | — | | | 92 | | | Other | | 185 | | | 1 | | | 7 | | | — | | | 193 | | | Total all other investments | | 277 | | | 1 | | | 7 | | | — | | | 285 | | Other assets – client-owned fractional shares | | 171 | | | — | | | — | | | — | | | 171 | | Subtotal | | 955 | | | 8,223 | | | 11 | | | (239) | | | 8,950 | | Other investments – private equity – measured at NAV | | | | | | | | | | 105 | | Total assets at fair value on a recurring basis | | $ | 955 | | | $ | 8,223 | | | $ | 11 | | | $ | (239) | | | $ | 9,055 | | | | | | | | | | | | | Liabilities at fair value on a recurring basis: | | | | | | | | | | | | Trading liabilities: | | | | | | | | | | | | Municipal and provincial obligations | | $ | 3 | | | $ | — | | | $ | — | | | $ | — | | | $ | 3 | | | Corporate obligations | | — | | | 651 | | | — | | | — | | | 651 | | | Government and agency obligations | | 164 | | | — | | | — | | | — | | | 164 | | Agency MBS and CMOs | | — | | | 42 | | | — | | | — | | | 42 | | | Total debt securities | | 167 | | | 693 | | | — | | | — | | | 860 | | Equity securities | | 31 | | | — | | | — | | | — | | | 31 | | | | | | | | | | | | | | Total trading liabilities | | 198 | | | 693 | | | — | | | — | | | 891 | | | Derivative liabilities: | | | | | | | | | | | | Interest rate | | 3 | | | 306 | | | — | | | (123) | | | 186 | | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange | | — | | | 2 | | | — | | | — | | | 2 | | Other | | — | | | — | | | 2 | | | — | | | 2 | | | Total derivative liabilities | | 3 | | | 308 | | | 2 | | | (123) | | | 190 | | Other payables – repurchase liabilities related to client-owned fractional shares | | 171 | | | — | | | — | | | — | | | 171 | | Total liabilities at fair value on a recurring basis | | $ | 372 | | | $ | 1,001 | | | $ | 2 | | | $ | (123) | | | $ | 1,252 | |
(1)Netting adjustments represent the impact of counterparty and collateral netting on our derivative balances included on our Condensed Consolidated Statements of Financial Condition. See Note 6 for additional information. (2)Our available-for-sale securities primarily consist of agency MBS, agency CMOs, and U.S. Treasury securities (“U.S. Treasuries”). See Note 5 for further information. (3)These assets are primarily comprised of U.S. Treasuries purchased to meet certain deposit requirements with clearing organizations. Level 3 recurring fair value measurements
The following tables present the changes in fair value for Level 3 assets and liabilities measured at fair value on a recurring basis. The realized and unrealized gains and losses in the tables may include changes in fair value that were attributable to both observable and unobservable inputs. In the following tables, gains/(losses) on trading and derivative instruments are reported in “Principal transactions” and gains/(losses) on other investments are reported in “Other” revenues on our Condensed Consolidated Statements of Income and Comprehensive Income. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended March 31, 2026 Level 3 instruments at fair value | | | Financial assets | | | Financial liabilities | | | Trading assets | | | | | Derivative assets | | | All other investments | | | Trading liabilities | | | | | $ in millions | | Other | | | | | Other | | | Other | | | Other | | | | Fair value beginning of period | | $ | 4 | | | | | | $ | — | | | | $ | 7 | | | | $ | — | | | | | | Total gains/(losses) included in earnings | | — | | | | | | 1 | | | | — | | | | 1 | | | | | Purchases and contributions | | 25 | | | | | | — | | | | — | | | | — | | | | | | Sales and distributions | | (27) | | | | | | (1) | | | | — | | | | — | | | | | Transfers: | | | | | | | | | | | | | | | | | | Into Level 3 | | — | | | | | | — | | | | — | | | | — | | | | | | Out of Level 3 | | — | | | | | | — | | | | — | | | | — | | | | | Fair value end of period | | $ | 2 | | | | | | $ | — | | | | $ | 7 | | | | $ | 1 | | | | | Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period | | $ | — | | | | | | $ | — | | | | $ | — | | | | $ | 1 | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six months ended March 31, 2026 Level 3 instruments at fair value | | | Financial assets | | | Financial liabilities | | | Trading assets | | | Derivative assets | | | | | All other investments | | | Trading liabilities | | | Derivative liabilities | | $ in millions | | Other | | | Other | | | | | Other | | | Other | | | Other | Fair value beginning of period | | $ | 4 | | | | $ | — | | | | | | $ | 7 | | | | $ | — | | | | $ | (2) | | Total gains/(losses) included in earnings | | 1 | | | | 2 | | | | | | — | | | | 1 | | | | 1 | | Purchases and contributions | | 50 | | | | — | | | | | | — | | | | — | | | | — | | | Sales and distributions | | (53) | | | | (2) | | | | | | — | | | | — | | | | 1 | | Transfers: | | | | | | | | | | | | | | | | | | Into Level 3 | | — | | | | — | | | | | | — | | | | — | | | | — | | | Out of Level 3 | | — | | | | — | | | | | | — | | | | — | | | | — | | Fair value end of period | | $ | 2 | | | | $ | — | | | | | | $ | 7 | | | | $ | 1 | | | | $ | — | | Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period | | $ | — | | | | $ | — | | | | | | $ | — | | | | $ | 1 | | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended March 31, 2025 Level 3 instruments at fair value | | | Financial assets | | | | | | | | | Financial liabilities | | | | Trading assets | | | Derivative assets | | | | | All other investments | | | | | | | | | Derivative liabilities | | $ in millions | | Other | | | Other | | | | | Other | | | | | | | | | Other | Fair value beginning of period | | $ | 2 | | | | $ | — | | | | | | $ | 7 | | | | | | | | | | $ | (2) | | | Total gains/(losses) included in earnings | | 1 | | | | 6 | | | | | | — | | | | | | | | | | 2 | | Purchases and contributions | | 21 | | | | — | | | | | | — | | | | | | | | | | — | | Sales and distributions | | (23) | | | | — | | | | | | — | | | | | | | | | | — | | Transfers: | | | | | | | | | | | | | | | | | | | | | Into Level 3 | | — | | | | — | | | | | | — | | | | | | | | | | — | | | Out of Level 3 | | — | | | | — | | | | | | — | | | | | | | | | | — | | Fair value end of period | | $ | 1 | | | | $ | 6 | | | | | | $ | 7 | | | | | | | | | | $ | — | | Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period | | $ | — | | | | $ | 8 | | | | | | $ | — | | | | | | | | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six months ended March 31, 2025 Level 3 instruments at fair value | | | Financial assets | | | | | | | | | | | | Trading assets | | | Derivative assets | | | | | All other investments | | | | | | | | | | | $ in millions | | Other | | | Other | | | | | Other | | | | | | | | | | Fair value beginning of period | | $ | 3 | | | | $ | 4 | | | | | | $ | 7 | | | | | | | | | | | Total gains/(losses) included in earnings | | 1 | | | | 2 | | | | | | — | | | | | | | | | | | Purchases and contributions | | 39 | | | | — | | | | | | — | | | | | | | | | | | Sales and distributions | | (42) | | | | — | | | | | | — | | | | | | | | | | | Transfers: | | | | | | | | | | | | | | | | | | | | | Into Level 3 | | — | | | | — | | | | | | — | | | | | | | | | | | | Out of Level 3 | | — | | | | — | | | | | | — | | | | | | | | | | | Fair value end of period | | $ | 1 | | | | $ | 6 | | | | | | $ | 7 | | | | | | | | | | | Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period | | $ | — | | | | $ | 2 | | | | | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
As of March 31, 2026, 9% of our assets and 1% of our liabilities were measured at fair value on a recurring basis. As of September 30, 2025, 10% of our assets and 2% of our liabilities were measured at fair value on a recurring basis. As of both March 31, 2026 and September 30, 2025, Level 3 assets represented less than 1% of our assets measured at fair value on a recurring basis.
Investments in private equity measured at net asset value per share
As more fully described in Note 2 of our 2025 Form 10-K, as a practical expedient, we utilize NAV or its equivalent to determine the recorded value of a portion of our private equity investments portfolio. We utilize NAV when the fund investment does not have a readily determinable fair value and the NAV of the fund is calculated in a manner consistent with the measurement principles of investment company accounting, including measurement of the investments at fair value.
Our private equity portfolio as of March 31, 2026 primarily included investments in third-party funds, including growth equity, venture capital, and mezzanine lending fund investments. Our investments cannot be redeemed directly with the funds. Our investments are monetized through the liquidation of underlying assets of fund investments, the timing of which is uncertain. The following table presents the recorded value and unfunded commitments related to our private equity investments portfolio. | | | | | | | | | | | | | | | | $ in millions | | Recorded value | | Unfunded commitment | | March 31, 2026 | | | | | | Private equity investments measured at NAV | | $ | 111 | | | $ | 36 | | | Private equity investments not measured at NAV | | 7 | | | | Total private equity investments | | $ | 118 | | | | | | | | | | September 30, 2025 | | | | | | Private equity investments measured at NAV | | $ | 105 | | | $ | 38 | | | Private equity investments not measured at NAV | | 7 | | | | | Total private equity investments | | $ | 112 | | | |
Financial instruments measured at fair value on a nonrecurring basis
The following table presents assets measured at fair value on a nonrecurring basis along with the valuation techniques and significant unobservable inputs used in the valuation of the assets classified as level 3. These inputs represent those that a market participant would take into account when pricing these instruments. Weighted averages are calculated by weighting each input by the relative fair value of the related financial instrument. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ in millions | | | | Level 2 | | Level 3 | | Total fair value | | Valuation technique(s) | | Unobservable input | | Range (weighted-average) | | March 31, 2026 | | | | | | | | | | | | | | | | Bank loans: | | | | | | | | | | | | | | | | Residential mortgage loans | | | | $ | 4 | | | $ | 7 | | | $ | 11 | | | Collateral or discounted cash flow (1) | | Prepayment rate | | 7 yrs. - 12 yrs. (10.6 yrs.) | | Corporate loans | | | | $ | — | | | $ | 155 | | | $ | 155 | | | Collateral or discounted cash flow (1) | | Recovery rate | | 55% - 87% (74%) | | Loans held for sale | | | | $ | 5 | | | $ | — | | | $ | 5 | | | N/A (2) | | N/A | | N/A | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | September 30, 2025 | | | | | | | | | | | | | | | | Bank loans: | | | | | | | | | | | | | | | | Residential mortgage loans | | | | $ | 5 | | | $ | 7 | | | $ | 12 | | | Collateral or discounted cash flow (1) | | Prepayment rate | | 7 yrs. - 12 yrs. (10.5 yrs.) | | Corporate loans | | | | $ | — | | | $ | 179 | | | $ | 179 | | | Collateral or discounted cash flow (1) | | Recovery rate | | 24% - 96% (76%) | | Loans held for sale | | | | $ | 31 | | | $ | — | | | $ | 31 | | | N/A | | N/A | | N/A | | | | | | | | | | | | | | | |
(1)The valuation techniques used to estimate the fair values are based on collateral value less selling costs for the collateral-dependent loans and discounted cash flows for loans that are not collateral-dependent. Unobservable inputs used in the collateral valuation technique are not meaningful and unobservable inputs used in the discounted cash flow valuation technique are presented in the table. (2)See the “Bank loans, net - Loans held for sale” section of Note 2 of our 2025 Form 10-K for information on the valuation techniques used in the valuation of our loans held for sale measured at fair value on a nonrecurring basis. Financial instruments not recorded at fair value
Many, but not all, of the financial instruments we hold were recorded at fair value on the Condensed Consolidated Statements of Financial Condition. The following table presents the estimated fair value and fair value hierarchy of financial assets and liabilities that are not recorded at fair value on the Condensed Consolidated Statements of Financial Condition at March 31, 2026 and September 30, 2025. This table excludes financial instruments that are carried at amounts which approximate fair value. See Note 3 of our 2025 Form 10-K for a discussion of our financial instruments that are not recorded at fair value. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ in millions | | | | Level 2 | | Level 3 | | Total estimated fair value | | Carrying amount | | March 31, 2026 | | | | | | | | | | | Financial assets: | | | | | | | | | | | Bank loans, net | | | | $ | 193 | | | $ | 54,173 | | | $ | 54,366 | | | $ | 54,662 | | Financial liabilities: | | | | | | | | | | | | Bank deposits - certificates of deposit | | | | $ | 2,320 | | | $ | — | | | $ | 2,320 | | | $ | 2,320 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Senior notes payable | | | | $ | 3,187 | | | $ | — | | | $ | 3,187 | | | $ | 3,521 | | | | | | | | | | | | | | September 30, 2025 | | | | | | | | | | | Financial assets: | | | | | | | | | | | Bank loans, net | | | | $ | 386 | | | $ | 50,362 | | | $ | 50,748 | | | $ | 51,345 | | Financial liabilities: | | | | | | | | | | | | Bank deposits - certificates of deposit | | | | $ | 1,943 | | | $ | — | | | $ | 1,943 | | | $ | 1,937 | | | | | | | | | | | | | | Senior notes payable | | | | $ | 3,299 | | | $ | — | | | $ | 3,299 | | | $ | 3,520 | |
|